Elite Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 40.00K shares.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 2.60M shares.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 1.13M shares.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2016-12-31 was 60.00K shares.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2026 was 8.73M shares, a 9603.70% increase from fiscal 2025.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 90.00K shares.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 112.50K shares, a 49.63% decline from fiscal 2015.
- Elite Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2015 was 223.33K shares, a 27.57% decline from fiscal 2014.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 40.00K shares 10-Q · filed 2026-08-13 | |
| 2026-03-31 | 2.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | 8.73M shares 10-K · filed 2026-06-29 |
| 2025-12-31 | 1.13M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-17 | |
| 2025-03-31 | 90.00K shares 10-K · filed 2025-06-30 | |
| 2016-12-31 | 60.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | |
| 2016-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-09 | |
| 2016-06-30 | 40.00K shares 10-Q · filed 2016-08-09 | |
| 2016-03-31 | 112.50K shares 10-K · filed 2016-06-15 | |
| 2015-03-31 | 223.33K shares 10-K · filed 2016-06-15 | |
| 2014-03-31 | 308.33K shares 10-K · filed 2016-06-15 | |
| 2013-03-31 | 0.00 shares 10-K · filed 2014-06-30 | |
| 2012-03-31 | 0.00 shares 10-K · filed 2013-06-21 |